CVSI
had a brutal last year, but is fighting for fresh support and just broke the longstanding bear trendline suggesting that a turnaround could be in the cards. -----------------------------
CV Sciences Inc (OTCMKTS:CVSI)
CV Sciences bills itself as a company that operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
The stock was the singular breakout market leader in the CBD space in 2018 until it got chopped down, first by Citron’s Andrew Left in a series of bearish tweets, and second by the cannabis and CBD bear market that dominated 2019. Now, with a fresh hold of the dollar level, the possibility of a recovery year beckons in 2020.